Mechanism of rhubarb in the treatment of hyperlipidemia

Hyperlipidemia poses a significant health risk, characterized by aberrant lipid metabolism culminating in elevated cholesterol and triglyceride levels, predisposing individuals to cardiovascular diseases and other chronic conditions. Lifestyle factors, genetic predisposition, and dietary habits contribute to its pathogenesis, exacerbating the global burden of chronic diseases.
Rhubarb, a renowned traditional Chinese medicine traced back to ancient texts, emerges as a promising therapeutic agent against hyperlipidemia. Over two millennia, rhubarb has been harnessed for its multifaceted pharmacological properties, encompassing hypolipidemic, antibacterial, anti-inflammatory, and antioxidant effects. Recent investigations underscore its potential in mitigating hyperlipidemia and associated complications. Studies elucidate the lipid-lowering potential of rhubarb's diverse chemical constituents, notably anthraquinones and stilbenes. Emodin, rhubarb acid, and rhubarb phenols emerge as pivotal players in modulating lipid metabolism, enhancing cholesterol excretion, and regulating gene expression associated with lipid homeostasis. Notably, rhubarb stilbenes exhibit remarkable efficacy in improving lipid profiles and ameliorating pathological features of fatty liver.
Despite promising preclinical evidence, clinical validation of rhubarb's lipid-lowering efficacy remains limited. Challenges include the scarcity of large-scale clinical trials and comparative toxicity data vis-à-vis conventional lipid-lowering drugs. Standardization of preparation methods, dosage optimization, and safety assessment are imperative for its clinical integration. Rhubarb holds immense potential as a therapeutic adjunct in hyperlipidemia management, pending comprehensive research addressing pivotal questions. Optimization of extraction methods, elucidation of optimal dosing regimens, and enhancement of bioavailability are critical imperatives. Furthermore, exploring synergistic interactions with existing pharmacotherapeutic agents and innovative drug delivery systems may augment its therapeutic efficacy while mitigating adverse effects. Robust translational research endeavors are warranted to unlock its full therapeutic potential and pave the way for its integration into mainstream clinical practice.